produit-antigon

Not available for sale.
Regulatory approval pending.

Do you want to know more about ISABO ?

    Your phone number

    I'm interested in

    ISABO

    Ultimate Safety
    and Traceability in Transfusion

     

    DOUBLE VERIFICATION AT BEDSIDE

    • Patient/bag ABO groups and Rh-D verification.
    • Electronic patient ID/bag verification.


    BENEFITS

    • Fast and intuitive process for transfusion staff.
    • Ultimate safety for patient and institution by reducing ABO bedside errors.
    • Full bag and patient traceability up to bedside.
    • Haemovigilance compliance.
    • Seamless IT connection with LIS through embedded Ethernet middleware protocol.

    ± 3 min ABO group and ID verification at bedside

    ISABO is a Point-Of-Care Testing (POCT) device able to, automatically perform an ABO-D compatibility test at the patient bedside with 100 % reliability.

    ISABO is intended to confirm patient and blood bag identity, in order to control ABO-D blood groups at patient bedside immediately before a transfusion.

    The test is the confirmation of earlier blood bank ABO- and D-blood typing of the recipient. It ensures the compatibility of blood types of the recipient and the blood to be transfused just before transfusion at bedside.

    “Based on 2 patents from ULB, ANTIGON is currently developing, with a consortium of regional and international partners/subcontractors, a first disruptive ABO POCT device aiming to improve drastically transfusion safety at bedside.”

    Thierry Baltus, CEO

    Fast biological test principle

    • The test uses principle of hemagglutination combined to filtration promoted by centrifugation.
    • Three blood group antigens (A, B and RhD) can be assessed simultaneously in separate test units on two different blood samples.
    • A negative control is included for each test.
    • Consumable disks (patent pending*) (transfer system included) can be stored at room temperature.

    Key features

    • System for the reading of barcodes of bag and patient.
    • System for the identification of users through their RFID badge.
    • Capable to manage minimum 10 patients simultaneously with associated blood bags.
    • Autonomy of at least 8 hours (in full use).
    • Charged and connected to hospital IT/LIS through Ethernet via its docking station.
    • Each device upgrades are synchronized with the middleware and applied to all other instruments of the hospital.

    New disruptive POCT ABO device technology

    APPLICATIONS

    Care Unit

    Laboratory

    Emergency

    Latest news from Antigon

    Keep me in touch !

    Subscribe to our mailing-list and you will receive the latest updates about our product directly in your mailbox.

      Contact us

      Any question ? Please feel free to contact us !

        ANTIGON S.A

        Biopark
        Avenue Auguste Picard, 48
        6041 Gosselies

        Tél. +32 (0)470 17 26 91
        info@antigon.eu

        TVA BE 0658 877 151

        Privacy Policy

        SITE INTERNET RÉALISÉ PAR wooops.agency